Skip to main content

Advertisement

SpringerLink
Log in

XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

X-ray cross complementing group 1 (XRCC1) polymorphisms and bladder cancer risk has been investigated for years, but the result in Asian population is till inconclusive. Thus, we performed this meta-analysis to determine the association of XRCC1 Arg194Trp, Arg280His, and Arg399Gln polymorphisms with bladder cancer risk in the Asian population. PubMed, EMBASE, and China National Knowledge Infrastructure were searched up to January 2013 to identify eligible studies. The association strength was measured with odd ratios (ORs) and 95 % confidence intervals (95 % CIs). A total of nine eligible studies, including 1,931 bladder cancer patients and 2,192 controls, were identified. Significant increased risk of bladder cancer was observed for Arg194Trp polymorphism (allele comparison OR = 1.20, 95 % CI: 1.06–1.36, Pheterogeneity = 0.11; dominant model OR = 1.20, 95 % CI: 1.02–1.41, Pheterogeneity = 0.37) and Arg280His polymorphism (heterozygote comparison OR = 1.87, 95 % CI: 1.21–2.90, Pheterogeneity = 0.01; dominant model OR = 1.75, 95 % CI: 1.05–2.90, Pheterogeneity = 0.01); however, Arg399Gln was not associated with susceptibility to bladder cancer. No evidence of publication bias was detected. Our meta-analysis results suggest that XRCC1 Arg194Trp and Arg280His polymorphisms are associated with significantly increased risk of bladder cancer in Asians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.

    Article  PubMed  Google Scholar 

  2. Yang L, Parkin DM, Li LD, Chen YD, Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991–2005. Br J Cancer. 2004;90:2157–66.

    PubMed Central  CAS  PubMed  Google Scholar 

  3. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, et al. Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World J Urol. 2007;25:285–95.

    Article  PubMed  Google Scholar 

  4. Bosetti C, Pira E, La Vecchia C. Bladder cancer risk in painters: a review of the epidemiological evidence, 1989–2004. Cancer Causes Control. 2005;16:997–1008.

    Article  PubMed  Google Scholar 

  5. de Laat WL, Jaspers NG, Hoeijmakers JH. Molecular mechanism of nucleotide excision repair. Genes Dev. 1999;13:768–85.

    Article  PubMed  Google Scholar 

  6. Shields PG, Harris CC. Molecular epidemiology and the genetics of environmental cancer. JAMA. 1991;266:681–7.

    Article  CAS  PubMed  Google Scholar 

  7. Garcia-Closas M, Egan KM, Newcomb PA, Brinton LA, Titus-Ernstoff L, et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet. 2006;119:376–88.

    Article  CAS  PubMed  Google Scholar 

  8. Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, et al. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol. 2006;164:297–302.

    Article  PubMed  Google Scholar 

  9. Lao T, Gu W, Huang Q. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking, and bladder cancer risk. Mutagenesis. 2008;23:523–32.

    Article  CAS  PubMed  Google Scholar 

  10. Wang C, Sun Y, Han R. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis. Urology. 2008;72:869–72.

    Article  PubMed  Google Scholar 

  11. Arizono K, Osada Y, Kuroda Y. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn J Clin Oncol. 2008;38:186–91.

    Article  PubMed  Google Scholar 

  12. Mittal RD, Mandal RK, Gangwar R. Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population. Mech Ageing Dev. 2012;133:127–32.

    Article  CAS  PubMed  Google Scholar 

  13. Wang M, Qin C, Zhu J, Yuan L, Fu G, et al. Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer. DNA Cell Biol. 2010;29:303–11.

    Article  CAS  PubMed  Google Scholar 

  14. Zhi Y, Yu J, Liu Y, Wei Q, Yuan F, et al. Interaction between polymorphisms of DNA repair genes significantly modulated bladder cancer risk. Int J Med Sci. 2012;9:498–505.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Huang J, Zhang J, Zhao Y, Liao B, Liu J, et al. The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese mainland population: a meta-analysis. Mol Biol Rep. 2011;38:4565–73.

    Article  CAS  PubMed  Google Scholar 

  16. Qiu MT, Hu JW, Ding XX, Yang X, Zhang Z, et al. Hsa-miR-499 rs3746444 polymorphism contributes to cancer risk: a meta-analysis of 12 studies. PLoS One. 2012;7:e50887.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, et al. Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol. 2005;162:201–11.

    Article  PubMed  Google Scholar 

  18. Wen H, Ding Q, Fang ZJ, Xia GW, Fang J. Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai. Int Urol Nephrol. 2009;41:855–64.

    Article  PubMed  Google Scholar 

  19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Hsu LI, Chiu AW, Huan SK, Chen CL, Wang YH, et al. SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan. Toxicol Appl Pharmacol. 2008;228:144–55.

    Article  CAS  PubMed  Google Scholar 

  21. Yang Q, Chen K, Han Q. Polymorphisms in XRCC1 and XRCC3 genes and susceptibility of bladder cancer (Chinese). Zhong Guo Wu Zhen Za Zhi. 2009;9:8383–4.

    CAS  Google Scholar 

  22. Zhang W, Xiang Y, Cheng J, Shao C, Fang R, et al. A case-control study of XRRC1 polymorphism and risk of bladder cancer. Zhong Guo Zhong Liu. 2006;10:667–72.

    Google Scholar 

  23. Wu W. Study on the relationship between polymorphisms of JWA and XRCCl genes and the susceptibility to bladder cancer. China: Lanzhou University; 2005.

    Google Scholar 

  24. Mittal RD, Singh R, Manchanda PK, Ahirwar D, Gangwar R, et al. XRCC1 codon 399 mutant allele: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy. Cancer Biol Ther. 2008;7:645–50.

    Article  CAS  PubMed  Google Scholar 

  25. Whitehouse CJ, Taylor RM, Thistlethwaite A, Zhang H, Karimi-Busheri F, et al. XRCC1 stimulates human polynucleotide kinase activity at damaged DNA termini and accelerates DNA single-strand break repair. Cell. 2001;104:107–17.

    Article  CAS  PubMed  Google Scholar 

  26. Taylor RM, Thistlethwaite A, Caldecott KW. Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol Cell Biol. 2002;22:2556–63.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, et al. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst). 2003;2:901–8.

    Article  CAS  Google Scholar 

  28. Lei YC, Hwang SJ, Chang CC, Kuo HW, Luo JC, et al. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat Res. 2002;519:93–101.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by the Shanghai Jiao Tong University Medical and Engineering Collaborative Research Fund Project (YG2012MS45).

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Urology, Shanghai Jiaotong University Affiliated Shanghai First People’s Hospital, 100 Haining Rd, Shanghai, 200080, People’s Republic of China

    Fei Zhang, Jian-Hong Wu, Wei Zhao & Hai-Tao Liu

Authors
  1. Fei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jian-Hong Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hai-Tao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hai-Tao Liu.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 120 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, F., Wu, JH., Zhao, W. et al. XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis. Tumor Biol. 34, 2659–2664 (2013). https://doi.org/10.1007/s13277-013-0816-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-0816-x

Keywords

Search

Navigation